Our Pricing

Compare Wegovy Prescription Weight Loss UK: Clinical Evidence and Treatment Options

Published on: June 03, 2026

When you compare Wegovy prescription weight loss UK options, transparent pricing and clinical expertise matter. At Cured Pharmacy, Wegovy (semaglutide) is available from £79.00 with a free online consultation from our UK-registered clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073). All prescription weight loss treatments require clinical assessment by a UK prescriber to ensure safety and suitability.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics a naturally occurring hormone that regulates appetite and food intake by acting on areas of the brain involved in appetite regulation.

In the landmark STEP 1 clinical trial, participants using semaglutide 2.4mg once weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. The treatment works by slowing gastric emptying, reducing hunger signals, and increasing feelings of fullness after meals, which helps patients adhere to a reduced-calorie diet more effectively.

Wegovy is administered as a once-weekly subcutaneous injection using a pre-filled pen device. The dose is gradually increased over 16-20 weeks to minimise gastrointestinal side effects, starting at 0.25mg and reaching the maintenance dose of 2.4mg weekly, subject to individual tolerability and prescriber assessment [2].

Compare Wegovy Prescription Weight Loss Options: Clinical Efficacy

When comparing prescription weight loss treatments available in the UK, clinical trial data provides the most reliable evidence. Wegovy demonstrated superior weight loss outcomes compared to earlier GLP-1 treatments in head-to-head studies, with participants maintaining significant weight reduction when combined with lifestyle interventions [1][2].

The STEP programme included over 4,500 participants across multiple trials, establishing semaglutide's efficacy profile in diverse populations. In STEP 2, which specifically enrolled participants with type 2 diabetes, semaglutide 2.4mg produced an average weight loss of 9.6% compared to 3.4% with semaglutide 1.0mg (the dose used for diabetes management) [2]. This demonstrates that higher doses specifically licensed for weight management produce meaningfully greater results.

Importantly, clinical trials showed that weight loss with Wegovy was accompanied by improvements in cardiovascular risk factors, including reductions in waist circumference, blood pressure, and HbA1c levels in participants with prediabetes or type 2 diabetes [1][2]. These metabolic benefits extend beyond the number on the scale, addressing the underlying health risks associated with obesity.

Long-Term Weight Maintenance

The STEP 4 trial examined weight maintenance after initial weight loss, finding that participants who continued semaglutide maintained their weight loss, while those switched to placebo regained approximately two-thirds of the weight they had lost [3]. This evidence highlights that prescription weight loss medications like Wegovy are intended for long-term use as part of chronic weight management, rather than short-term interventions.

Wegovy Prescription Cost UK: Transparent Pricing at Cured Pharmacy

At Cured Pharmacy, Wegovy is priced from £79.00 per pen, with transparent upfront pricing displayed before your consultation. Unlike some providers, we show you the exact cost before you complete your clinical assessment, so there are no surprises. Our pricing includes the medication, prescription service, and discreet UK delivery.

The final cost depends on your prescribed dose, which your UK prescriber determines based on your medical history, current medications, and treatment goals. Wegovy follows a dose-escalation schedule, starting at lower doses and gradually increasing to the maintenance dose of 2.4mg weekly, subject to tolerability and clinical response.

We guarantee the lowest prices in the UK for genuine, UK-licensed medicines. All Wegovy pens dispensed by Cured Pharmacy are sourced through licensed UK wholesalers and are identical to those available through high-street pharmacies. Our GPhC registration (9012511) ensures full regulatory compliance and patient safety.

What's Included in Your Wegovy Prescription

Your Wegovy prescription from Cured Pharmacy includes a free online consultation (typically completed in under 3 minutes), clinical assessment by a UK-registered prescriber, the prescribed medication dispensed by our registered pharmacy team, and discreet delivery to your chosen UK address. Follow-up consultations and dose adjustments are managed through your online account, with ongoing support from our clinical team throughout your treatment journey.

Comparing Weight Loss Injection Options: Wegovy vs Alternatives

Several prescription weight loss injections are now licensed in the UK, each with distinct mechanisms, dosing schedules, and clinical evidence. Understanding these differences helps you and your prescriber select the most appropriate treatment for your individual circumstances.

Semaglutide-based treatments like Wegovy work as GLP-1 receptor agonists, while newer dual-agonist medications target both GLP-1 and GIP receptors. Earlier GLP-1 treatments require daily injections rather than weekly administration. Clinical trial data shows varying degrees of average weight loss across these options, with newer treatments generally demonstrating greater efficacy in head-to-head comparisons [4][5].

Your UK prescriber will consider factors including your BMI, weight loss goals, medical history, current medications, previous treatment responses, and practical preferences like injection frequency. Some patients prioritise maximum efficacy, while others may prefer treatments with longer safety track records or different side effect profiles. There is no single 'best' option—the right treatment is the one that's clinically appropriate, well-tolerated, and sustainable for you long-term.

Wegovy Side Effects and Safety Considerations

The most common side effects of Wegovy are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal pain [1][2]. These effects are typically mild to moderate, occur most frequently during dose escalation, and tend to decrease over time as your body adjusts to the medication. The gradual dose-escalation schedule is specifically designed to minimise these side effects.

More serious but rare side effects include pancreatitis, gallbladder problems, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Wegovy carries a boxed warning in some jurisdictions regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [2]. Your prescriber will assess your personal and family medical history for contraindications before prescribing.

Wegovy is not suitable for everyone. It should not be used during pregnancy or breastfeeding, in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, or in those with a history of severe gastrointestinal disease. Your online consultation will identify any contraindications, and our UK prescribers will only approve treatment when clinically appropriate and safe.

Managing Side Effects

If you experience side effects while taking Wegovy, several strategies can help. Eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and not lying down immediately after eating may reduce gastrointestinal symptoms. Your prescriber may also adjust your dose escalation schedule if side effects are problematic. Always report persistent or severe side effects to your healthcare provider, and contact NHS 111 or emergency services if you experience severe abdominal pain, as this may indicate pancreatitis requiring immediate medical attention.

Starting Your Wegovy Prescription at Cured Pharmacy

Beginning your weight loss journey with Wegovy at Cured Pharmacy is straightforward and fully online. Start by completing our free clinical consultation questionnaire, which typically takes under 3 minutes. You'll provide information about your medical history, current medications, weight loss goals, and any previous weight management attempts.

A UK-registered prescriber from our clinical team reviews your consultation within hours. If Wegovy is clinically appropriate for you, they'll issue a prescription and our pharmacy team will dispense your medication in discreet, unmarked packaging. Your first delivery includes the starting dose pen and clear instructions for injection technique, storage, and dose escalation schedule.

Throughout your treatment, you'll have access to ongoing clinical support through your online account. As you progress through the dose-escalation schedule, you'll complete brief follow-up consultations to monitor your response, side effects, and any dose adjustments needed. Our team is available by phone (+44 116 4646009) during business hours for any questions or concerns. All prescription weight loss treatments at Cured Pharmacy are subject to continued prescriber approval based on your individual response and tolerability.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
3. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and is subject to prescriber approval based on individual suitability. Weight loss results vary between individuals, and clinical trial data represents average outcomes in controlled study conditions. Never purchase prescription medications from unregistered sources.